The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...
Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...
Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.
The Swiss drug development company Windward Bio recently announced that ... TSLP has been found to play a key role in ...
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
FRIDAY, Jan. 3, 2025 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with ...
Phase 3 trial shows Nucala reduces COPD exacerbations ... Also Read: GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market – Here's Why People with CRSwNP ...
Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...